Analysis of FDA Drug GMP Warning Letters for FY 2022 by GMP expert Barbara W. Unger.
Get the latest in-depth analysis of FDA Drug GMP Warning Letters for FY 2022 by GMP expert Barbara W. Unger. There was unprecedented upheaval in FDA activities, so this is a report you don’t want to miss.
✔ Combined two-year analysis of FDA Warning Letters
✔ FDA enforcement trends as indicated by this analysis
✔ How these trends compare to enforcement trends since FY2013
Offered Free by: Redica Systems
See All Resources from: Redica Systems
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.